The effect of empagliflozin on right ventricular function in heart failure patients with reduced ejection fraction: analysis from the randomized empire hf clinical trial

Back

ESC Professional Premium Access

The effect of empagliflozin on right ventricular function in heart failure patients with reduced ejection fraction: analysis from the randomized empire hf clinical trial

Session: Probing deeper into the pathophysiology of heart failure

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Miss M. Callesen Hansen (Odense, DK)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Miss Maria Callesen Hansen

Odense University Hospital, Odense (Denmark)

0 follower

5 more presentations in this session

Cardiac contractility index, a novel biomarker of incident heart failure amongst people with normal left ventricular ejection fraction in the UK Biobank

Speaker: Doctor O. Brown (Leeds, GB)

Significant correlation between the extent of myocardial fibrosis and heart failure parameters in patients undergoing transcatheter aortic valve implantation.

Speaker: Doctor K. Yamaguchi (Suita, JP)

Genetic and phenotypic architecture of biventricular trabeculation

Speaker: Doctor K. McGurk (London, GB)

Neurodegeneration is highly associated with comorbidity burden in HFrEF patients

Speaker: Doctor S. Prausmueller (Vienna, AT)

Exome sequencing in over 63,000 patients in TIMI trials uncovers pathogenic cardiomyopathy variant carriers with high risk for heart failure and cardiovascular death

Speaker: Doctor S. Kany (Hamburg, DE)

Access the full session

Probing deeper into the pathophysiology of heart failure

Speakers: Miss M. Callesen Hansen, Doctor O. Brown, Doctor K. Yamaguchi, Doctor K. McGurk, Doctor S. Prausmueller...

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources